Marker Therapeutics Inc (MRKR)

[microcapbiotech]

MARKER THERAPEUTICS TO PARTICIPATE IN VIRTUAL ROUNDTABLE WITH KEY OPINION LEADERS TO DISCUSS CLINICAL LANDSCAPE OF CAR-T CELL THERAPIES ON AUGUST 9, 2023
Beyond CAR-T, What’s Next for Cell Therapy
During the one virtual event, featured panelists will provide an overview and discuss the limitations of CAR-T cell therapies. Panelists will also highlight the potential impact and unique merits of the multiple tumor-associated antigen (multiTAA) targeted therapy Marker is developing in comparison to single antigen targeted therapies.
The extensive knowledge and unique perspectives of the panelists promises a profound and impactful discussion.
The roundtable discussion will be accessible online, allowing participants worldwide to join and take part in this crucial dialogue.
https://ir.markertherapeutics.com/news-releases/news-release-details/marker-therapeutics-participate-virtual-roundtable-key-opinion
To attend the roundtable discussion, please register at:
HTTPS://WEB.CVENT.COM/EVENT/D7B7A2D7-E892-4876-9924-7020190FA2B7/REGPROCESSSTEP1?_HSENC=P2ANQTZ-9UMFUESQPKFCBIXG4ARSLL6V1TGGRXMTCDL5DWRJ-VDBAEXEJABKIHERY3SC2BTO9YMC-VZ2CEUBGQM6KJVNIYWASMJW&_HSMI=267259723&UTM_CAMPAIGN=VIRTUAL%20SALONS&UTM_CONTENT=2672